These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18674729)

  • 1. Re: Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with carvedilol therapy alone.
    Koracevic G
    J Nucl Cardiol; 2008; 15(4):604. PubMed ID: 18674729
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with carvedilol therapy alone.
    Toyama T; Hoshizaki H; Yoshimura Y; Kasama S; Isobe N; Adachi H; Oshima S; Taniguchi K
    J Nucl Cardiol; 2008; 15(1):57-64. PubMed ID: 18242480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To add amiodarone or not: that is the question.
    Zimmerman MJ; Gerson MC
    J Nucl Cardiol; 2008; 15(1):7-9. PubMed ID: 18242473
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy.
    Paraskevaidis IA; Tsiapras D; Karavolias G; Adamopoulos S; Dodouras T; Cokkinos P; Kremastinos DT
    J Am Soc Echocardiogr; 2006 May; 19(5):529-35. PubMed ID: 16644436
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
    Tsuda E; Matsuo M; Sakaguchi H; Hayashi T; Hosoda K; Miyazaki A
    Pediatr Int; 2010 Feb; 52(1):e39-42. PubMed ID: 20158646
    [No Abstract]   [Full Text] [Related]  

  • 6. Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.
    Gerson MC; Craft LL; McGuire N; Suresh DP; Abraham WT; Wagoner LE
    J Nucl Cardiol; 2002; 9(6):608-15. PubMed ID: 12466785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.
    Toyama T; Hoshizaki H; Seki R; Isobe N; Adachi H; Naito S; Oshima S; Taniguchi K
    J Nucl Med; 2003 Oct; 44(10):1604-11. PubMed ID: 14530474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study.
    Bajcetic M; Kokic Nikolic A; Djukic M; Kosutic J; Mitrovic J; Mijalkovic D; Jovanovic I; Simeunovic S; Spasic MB; Samardzic R
    Clin Ther; 2008 Apr; 30(4):702-14. PubMed ID: 18498919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.
    Paraskevaidis I; Farmakis D; Parissis JT; Dodouras T; Filippatos G; Tsiapras D; Kremastinos DT
    J Card Fail; 2007 Mar; 13(2):108-13. PubMed ID: 17395050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.
    Cice G; Tagliamonte E; Ferrara L; Iacono A
    Eur Heart J; 2000 Aug; 21(15):1259-64. PubMed ID: 10924316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of carvedilol on heart rate and blood pressure variability in subjects with chronic heart failure.
    Piccirillo G; Luparini RL; Celli V; Moisè A; Lionetti M; Marigliano V; Cacciafesta M
    Am J Cardiol; 2000 Dec; 86(12):1392-5, A6. PubMed ID: 11113424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol and dose-related improvements in left ventricular function.
    Ghali JK
    Circulation; 1997 Oct; 96(8):2743-4. PubMed ID: 9355928
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
    Kurum T; Tatli E; Yuksel M
    Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol in heart failure: the MOCHA trial.
    Osterziel KJ
    Circulation; 1997 Oct; 96(8):2742; author reply 2743-4. PubMed ID: 9355927
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of carvedilol on heart rate response to exercise in digitalised patients with heart failure in atrial fibrillation due to idiopathic dilated cardiomyopathy.
    Agarwal AK; Venugopalan P
    Eur J Heart Fail; 2001 Aug; 3(4):437-40. PubMed ID: 11511429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy.
    Maunoury C; Acar P; Sidi D
    Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1651-6. PubMed ID: 14504829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of sympathetic nervous system activity during administration of carvedilol in rats with dilated cardiomyopathy.
    Watanabe K; Abe Y; Sato S; Wahed M; Wen J; Narasimman G; Ma M; Ali F; Saito Y; Suresh P; Shirai K; Soga M; Nagai Y; Takahashi T; Hasegawa G; Naito M; Tachikawa H; Tanabe N; Kodama M; Aizawa Y; Yamaguchi K; Miyazaki M; Kakemi M
    J Cardiovasc Pharmacol; 2003 Dec; 42 Suppl 1():S93-7. PubMed ID: 14871037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
    Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
    Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.